24 devices · GMDN 57464
Myo-D1 protein rhabdomyosarcoma marker IVD, antibody devices are laboratory tests that detect the presence of Myo-D1 protein in clinical specimens to help identify rhabdomyosarcoma, a type of cancer that affects soft tissues. These tests use antibodies to bind specifically to Myo-D1 protein, providing qualitative or quantitative results for diagnostic purposes.
These in vitro diagnostic devices are typically supplied as antibody preparations and are regulated according to regional medical device requirements. They are intended for professional use in clinical laboratories to assist in the diagnosis of rhabdomyosarcoma through the detection of specific protein markers.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.